Grants and Contracts Details
Description
The progressive loss of sight that results from diseases like retinitis pigmentosa (RP)
and macular degeneration is especially devastating because it is currently irreversible.
Breakthrough therapeutic strategies such as gene therapy and cell-based
transplantation are on the horizon, but gene therapy is only an option for a small group
of patients, and several technical and theoretical challenges must be overcome before
cell transplantation becomes a viable strategy. One complementary approach to treating
retinal degenerative diseases is to find ways to promote endogenous regeneration in
the diseased or damaged retina. Across the animal kingdom, several vertebrate
species, including fish, amphibians, and reptiles, are capable of regenerating their
retinal neurons in response to acute injury. Research into the mechanisms regulating
retinal regeneration in these species has yielded valuable information and highlighted
the critical role of retinal Muller glia as the source of regenerating cells. However, to
translate these findings into therapies, it would be helpful to incorporate an animal
model that more closely mirrors human ocular physiology to probe the regenerative
potential of the mammalian retina. In recent years, spiny mice (Acomys) have become
the focus of intense research for their ability to heal skin wounds without scars. Further
studies have revealed that spiny mice exhibit complex musculoskeletal tissue
regeneration and possess cytoprotective mechanisms that limit tissue damage to the
heart and spinal cord. This raises the question of whether these mammals might
regenerate retinal neurons in response to damage, or whether they can resist damage
to preserve retinal function. We have obtained exciting preliminary data that the former
may indeed be the case. To further explore this question, we propose in this pilot study
to rigorously test the hypothesis that the spiny mouse possesses the capacity to
regenerate retinal neurons in response to damage, and to take the first steps in
determining the underlying biological mechanism. To do this, we propose three specific
aims: 1) we will monitor cell death, cell proliferation, and cell differentiation in the spiny
mouse retina in response to ablation of inner retinal neurons; we will compare this
response to that of outbred laboratory mice (Mus musculus) which are not capable of
retinal regeneration; 2) we will use a high energy laser to ablate the retinal
photoreceptors in Acomys and Mus retinas, and will examine the same responses as in
Aim 1; and 3) we will employ single-cell RNA-Sequencing (scRNA-Seq) at several time
points over the course of two weeks following damage to characterize how subtle
differences in cellular phenotypes regulate the different repair outcomes in Acomys vs.
Mus retinas. We will then compare our scRNA-seq data with previously published
datasets from animal models that are capable of full retinal regeneration, which will
allow us to identify common and distinct mechanisms of retinal repair and regeneration
in the mammalian retina. This study will be the first of its kind to document the natural
regenerative potential of any mammalian retina and may identify promising avenues for
promoting regeneration in human patients with retinal degenerative diseases.
Status | Finished |
---|---|
Effective start/end date | 1/1/22 → 4/30/23 |
Funding
- Retina Research Foundation: $45,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.